These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 8480059)
1. [Diabetes mellitus in the elderly: a study on its clinical presentation, C-peptide reserve, and immunogenetic markers of insulin dependence]. Seclén Santisteban S; Alvarez Huamán RI; Chantres Antoranz MT; Serrano Ríos M Rev Clin Esp; 1993 Mar; 192(4):162-8. PubMed ID: 8480059 [TBL] [Abstract][Full Text] [Related]
2. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin]. Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176 [TBL] [Abstract][Full Text] [Related]
3. Demonstration of islet cell antibodies in apparently non-insulin dependent diabetic patients; a marker for the later development of insulin dependency. Katsura H; Itoh N; Hanafusa T; Kono N; Tarui S Med J Osaka Univ; 1991 Mar; 40(1-4):67-71. PubMed ID: 1369659 [TBL] [Abstract][Full Text] [Related]
4. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study. Savage S; Estacio RO; Jeffers B; Schrier RW Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587 [TBL] [Abstract][Full Text] [Related]
5. The value of basal C peptide and its relationship with pancreatic autoantibodies in young adults with type 2 diabetes mellitus. Vlad A; Serban V; Sima A; Timar R; Roşu M Rom J Intern Med; 2004; 42(2):333-41. PubMed ID: 15529624 [TBL] [Abstract][Full Text] [Related]
7. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086 [TBL] [Abstract][Full Text] [Related]
8. [Detection of antibodies against pancreatic islet cells in clinical practice]. Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715 [TBL] [Abstract][Full Text] [Related]
9. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners]. Fabian W; Majkowska L; Stefański A; Moleda P Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234 [TBL] [Abstract][Full Text] [Related]
10. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group. Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390 [TBL] [Abstract][Full Text] [Related]
11. Autoimmune markers in slow type 1 diabetes: confrontation to type 1 diabetes. Desailloud R; Fajardy I; Vambergue A; Prevost G; Pigny P; Fontaine P Diabetes Metab; 2000 Nov; 26(5):353-60. PubMed ID: 11119014 [TBL] [Abstract][Full Text] [Related]
12. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2. Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100 [TBL] [Abstract][Full Text] [Related]
13. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus. Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623 [TBL] [Abstract][Full Text] [Related]
14. [C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus]. Perusicová J; Bárová H; Hill M; Masek Z Vnitr Lek; 2002 Jun; 48(6):490-9. PubMed ID: 12132349 [TBL] [Abstract][Full Text] [Related]
15. [Latent autoimmune (type 1) diabetes mellitus in patients originally classified as type 2. Divergence of etiologic markers]. Martinka E; Straková J; Galajda P; Shawkatová I; Buc M Cas Lek Cesk; 2000 Mar; 139(4):120-3. PubMed ID: 10838742 [TBL] [Abstract][Full Text] [Related]
16. [Prevalence of type 1 diabetes-specific autoantibodies and of certain HLA patterns in celiac disease]. Schilling I; Conrad K; Füssel M; Henker J Dtsch Med Wochenschr; 2003 Jan; 128(5):185-9. PubMed ID: 12557109 [TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and aetiological classification of insulin-dependent diabetes in the elderly. Kilvert A; Fitzgerald MG; Wright AD; Nattrass M Q J Med; 1986 Sep; 60(233):865-72. PubMed ID: 3306756 [TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase. Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268 [TBL] [Abstract][Full Text] [Related]
19. [New findings on the pathogenesis of diabetes mellitus]. Keller U Schweiz Med Wochenschr; 1986 Jan; 116(3):66-71. PubMed ID: 3511524 [TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase. Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]